| Ytd | -0.64% | |
| 1y | -8.99% |
| Open | 13.86 | Prev Close | 13.93 | Low | 13.86 | High | 14.10 | Mkt Cap | 288.11M |
| Vol | 4.26K | Avg Vol | 83.28K | EPS | -0.10 | P/E | -139.30 | Forward P/E | -2.17 |
| Beta | 0.80 | Short Ratio | 12.75 | Inst. Own | 17.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 14.93 | 200-d Avg | 15.38 | 1yr Est | 1.00 |
AMRN News
DUBLIN, Ireland and BRIDGEWATER, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NAS
Amarin (AMRN) witnesses a hammer chart pattern, indicating support found by the stock after losing s
Gainers Crinetics Pharmaceuticals (NASDAQ:CRNX) stock increased by 98.9% to $83.59 during Tuesday&#
Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular
Clinically Validated, Increasingly Prescribed, Widely Reimbursed, and Affordable, VASCEPA Expected t
Here is how Amarin (AMRN) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector
https://www.supremecourt.gov/opinions/25pdf/24-889_5i36.pdf
Amarin Corporation plc (NASDAQ:AMRN) (Amarin), a company committed to advancing the science of cardi
DUBLIN and BRIDGEWATER, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN)
Iovance matches Q1 earnings estimates, but weaker-than-expected Amtagvi and Proleukin sales sent sha
Amarin (AMRN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about t
AMRN beats earnings and sales estimates as Vascepa sales rise and cost cuts take hold, while the par
Amarin Corporation plc (AMRN) Q1 2026 Earnings Call Transcript
Total Revenue Increased Led by Higher International Sales Generated Positive Cash Flow and Reiterate
Here is how Amarin (AMRN) and BioAge Labs, Inc. (BIOA) have performed compared to their sector so fa
DUBLIN and BRIDGEWATER, N.J., April 15, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMR
Amarin has one drug, and it has lost key patent protections. The company is cutting costs in an effo
Amarin shares surge 37.7% in a year as restructuring, cost cuts and expanding Vazkepa partnerships f
Amarin's results depend on a single medicine that is already facing generic competition. By contrast
Amarin (NASDAQ: AMRN) executives told investors that 2025 marked a "substantial achievement" year as
AMRN swings to Q4 profit and beats estimates, but revenues decline 21% as Vascepa sales slide and sh
Amarin Corporation plc (AMRN) Q4 2025 Earnings Call Transcript
DUBLIN and BRIDGEWATER, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN
AMRN, AMTB and AAWH have been added to the Zacks Rank #5 (Strong Sell) List on January 28th, 2026.
On Thursday, 369 companies hit new 52-week lows.
On Tuesday, 647 companies set new 52-week lows.
On Tuesday, 386 stocks made new 52-week lows.
During the session on Thursday, 461 stocks hit new 52-week lows.
On Thursday, 1076 companies hit new 52-week lows.
Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report qua
On Wednesday, 807 companies reached new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 o
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Friday
Stocks That Hit 52-Week Highs On Tuesday